MERCORELLI, BEATRICE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.651
AS - Asia 1.484
EU - Europa 1.034
AF - Africa 341
SA - Sud America 339
OC - Oceania 34
Continente sconosciuto - Info sul continente non disponibili 20
Totale 6.903
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.457
SG - Singapore 530
CN - Cina 378
BR - Brasile 225
IT - Italia 215
HK - Hong Kong 152
DE - Germania 129
FI - Finlandia 97
VN - Vietnam 71
RU - Federazione Russa 59
PL - Polonia 53
SE - Svezia 53
NL - Olanda 43
FR - Francia 42
KR - Corea 41
GB - Regno Unito 40
UA - Ucraina 36
IN - India 27
AR - Argentina 25
AT - Austria 23
CA - Canada 21
CI - Costa d'Avorio 21
IL - Israele 19
IE - Irlanda 17
CZ - Repubblica Ceca 15
TR - Turchia 15
MX - Messico 14
PY - Paraguay 14
RE - Reunion 14
ZA - Sudafrica 14
GH - Ghana 13
HR - Croazia 13
ID - Indonesia 13
LU - Lussemburgo 13
NC - Nuova Caledonia 13
NI - Nicaragua 13
CW - ???statistics.table.value.countryCode.CW??? 12
HT - Haiti 12
KG - Kirghizistan 12
LB - Libano 12
MA - Marocco 12
MY - Malesia 12
SK - Slovacchia (Repubblica Slovacca) 12
AZ - Azerbaigian 11
CD - Congo 11
EG - Egitto 11
ET - Etiopia 11
GR - Grecia 11
GT - Guatemala 11
HU - Ungheria 11
IS - Islanda 11
JP - Giappone 11
MR - Mauritania 11
MU - Mauritius 11
MZ - Mozambico 11
SA - Arabia Saudita 11
SN - Senegal 11
UY - Uruguay 11
AM - Armenia 10
BE - Belgio 10
BO - Bolivia 10
BS - Bahamas 10
BW - Botswana 10
BZ - Belize 10
CL - Cile 10
DK - Danimarca 10
ES - Italia 10
GA - Gabon 10
GF - Guiana Francese 10
KE - Kenya 10
ML - Mali 10
PA - Panama 10
PR - Porto Rico 10
RS - Serbia 10
VE - Venezuela 10
CH - Svizzera 9
CR - Costa Rica 9
CU - Cuba 9
DJ - Gibuti 9
DO - Repubblica Dominicana 9
GP - Guadalupe 9
IR - Iran 9
JM - Giamaica 9
JO - Giordania 9
KZ - Kazakistan 9
LY - Libia 9
MD - Moldavia 9
PE - Perù 9
PK - Pakistan 9
TN - Tunisia 9
TW - Taiwan 9
TZ - Tanzania 9
UZ - Uzbekistan 9
AL - Albania 8
AO - Angola 8
BB - Barbados 8
BF - Burkina Faso 8
BG - Bulgaria 8
BY - Bielorussia 8
CY - Cipro 8
Totale 6.575
Salva come PNG Salva come JPEG
Città #
Fairfield 515
Ashburn 371
Singapore 349
Woodbridge 264
Chandler 232
Houston 228
Cambridge 195
Seattle 194
Ann Arbor 190
Hong Kong 148
Wilmington 144
Beijing 122
Santa Clara 97
Boardman 69
Helsinki 54
San Diego 51
Jacksonville 47
Princeton 43
Hefei 42
Los Angeles 40
Munich 37
Bytom 35
Seoul 32
Roxbury 31
Guangzhou 28
Medford 28
Padova 27
Dearborn 25
Ho Chi Minh City 24
Columbus 22
New York 22
Abidjan 21
São Paulo 21
Des Moines 20
Nanjing 20
Council Bluffs 18
Shanghai 17
Buffalo 15
Dong Ket 15
Dublin 15
Frankfurt am Main 14
Accra 13
Brooklyn 13
Chicago 13
Managua 13
Noumea 13
Hanoi 12
Milan 12
Shenyang 12
Baku 11
Dakar 11
Johannesburg 11
Maputo 11
Nouakchott 11
Perugia 11
Willemstad 11
Kinshasa 10
Naples 10
Nassau 10
Nuremberg 10
Pune 10
Redondo Beach 10
Rome 10
Vienna 10
Yerevan 10
Amman 9
Bamako 9
Bishkek 9
Boston 9
Gaborone 9
Havana 9
Lappeenranta 9
Libreville 9
London 9
Panama City 9
San José 9
Turku 9
Warsaw 9
Addis Ababa 8
Bridgetown 8
Castries 8
Cayenne 8
Dar es Salaam 8
Elk Grove Village 8
Kharkiv 8
Kigali 8
Montevideo 8
Niamey 8
Phnom Penh 8
Salt Lake City 8
Berlin 7
Chisinau 7
Conakry 7
Djibouti 7
Lusaka 7
Nairobi 7
Norwalk 7
San Juan 7
Tel Aviv 7
Tripoli 7
Totale 4.433
Salva come PNG Salva come JPEG
Nome #
4,6-Diphenylpyridines as Promising Novel Anti-Influenza Agents Targeting the PA-PB1 Protein-Protein Interaction: Structure-Activity Relationships Exploration with the Aid of Molecular Modeling 294
A Broad anti-influenza hybrid small molecule that potently disrupts the interaction of polymerase acidic protein-basic protein 1 (PA-PB1) subunits 228
Antiviral strategies against influenza virus: towards new therapeutic approaches. 224
The isoquinoline alkaloid berberine inhibits human cytomegalovirus replication by interfering with the viral Immediate Early-2 (IE2) protein transactivating activity 218
Potent and broad-spectrum cycloheptathiophene-3-carboxamide compounds that target the PA-PB1 interaction of influenza virus RNA polymerase and possess a high barrier to drug resistance 212
Drug Repurposing Approach Identifies Inhibitors of the Prototypic Viral Transcription Factor IE2 that Block Human Cytomegalovirus Replication 210
Role of homodimerization of human cytomegalovirus DNA polymerase accessory protein UL44 in origin-dependent DNA replication in cells. 210
Drug Repurposing for Viral Infectious Diseases: How Far Are We? 205
Small molecule inhibitors of influenza A and B viruses that act by disrupting subunit interactions of the viral polymerase. 200
A quantitative LumiFluo assay to test inhibitory compounds blocking p53 degradation induced by human papillomavirus oncoprotein E6 in living cells 194
A novel small-molecule inhibitor of the human papillomavirus E6-p53 interaction that reactivates p53 function and blocks cancer cells growth 190
Early inhibitors of human cytomegalovirus: State-of-art and therapeutic perspectives. 186
Structural investigation of cycloheptathiophene-3-carboxamide derivatives targeting influenza virus polymerase assembly. 184
The 6-Aminoquinolone WC5 Inhibits Human Cytomegalovirus Replication at an Early Stage by Interfering with the Transactivating Activity of Viral Immediate-Early 2 Protein 183
Optimization of Small-Molecule Inhibitors of Influenza Virus Polymerase: From Thiophene-3-Carboxamide to Polyamido Scaffolds 180
Design, synthesis, and evaluation of WC5 analogues as inhibitors of human cytomegalovirus Immediate-Early 2 protein, a promising target for anti-HCMV treatment. 178
A point mutation in a herpesvirus polymerase determines neuropathogenicity. 175
Approaches for the generation of new anti-cytomegalovirus agents: identification of protein-protein interaction inhibitors and compounds against the HCMV IE2 protein. 173
A 6-Aminoquinolone Compound, WC5, with Potent and Selective Anti-Human Cytomegalovirus Activity 173
Drug Repurposing Campaigns for Human Cytomegalovirus Identify a Natural Compound Targeting the Immediate-Early 2 (IE2) Protein: A Comment on "The Natural Flavonoid Compound Deguelin Inhibits HCMV Lytic Replication within Fibroblasts" 168
The Human Cytomegalovirus DNA Polymerase Processivity Factor UL44 is Modified by SUMO in a DNA-dependent manner 161
Repurposing the clinically approved calcium antagonist manidipine dihydrochloride as a new early inhibitor of human cytomegalovirus targeting the Immediate-Early 2 (IE2) protein 161
The 6-Aminoquinolone WC5 Inhibits Different Functions of the Immediate-Early 2 (IE2) Protein of Human Cytomegalovirus That Are Essential for Viral Replication. 156
The antifungal drug isavuconazole inhibits the replication of human cytomegalovirus (HCMV) and acts synergistically with anti-HCMV drugs 153
Binding parameters and thermodynamics of the interaction of the human cytomegalovirus DNA polymerase accessory protein, UL44, with DNA: implications for the processivity mechanism 151
Human cytomegalovirus DNA replication: antiviral targets and drugs. 146
Divide et impera: An In Silico Screening Targeting HCMV ppUL44 Processivity Factor Homodimerization Identifies Small Molecules Inhibiting Viral Replication 140
The dimeric form of hpv16 e6 is crucial to drive yap/taz upregulation through the targeting of hscrib 137
Indomethacin-based PROTACs as pan-coronavirus antiviral agents 135
Targeted disruption of e6/p53 binding exerts broad activity and synergism with paclitaxel and topotecan against hpv-transformed cancer cells 134
The Clinically Approved Antifungal Drug Posaconazole Inhibits Human Cytomegalovirus Replication 131
Design, synthesis, and biological evaluation of first-in-class indomethacin-based PROTACs degrading SARS-CoV-2 main protease and with broad-spectrum antiviral activity 129
Human Cytomegalovirus Inhibitor AL18 Also Possesses Activity against Influenza A and B Viruses. 129
Sulfated Derivatives of Escherichia coli K5 Polysaccharide are Potent Inhibitors of Human Cytomegalovirus. 126
Discovery of novel SARS-CoV-2 inhibitors targeting the main protease Mpro by virtual screenings and hit optimization 124
Synergistic activity of an RNA polymerase PA-PB1 interaction inhibitor with oseltamivir against human and avian influenza viruses in cell culture and in ovo 119
A small molecule targeting the interaction between human papillomavirus E7 oncoprotein and cellular phosphatase PTPN14 exerts antitumoral activity in cervical cancer cells 118
Small-Molecule Inhibitor of Flaviviral NS3-NS5 Interaction with Broad-Spectrum Activity and Efficacy In Vivo 108
Design, Synthesis, and Biological Evaluation of Trisubstituted Piperazine Derivatives as Noncovalent Severe Acute Respiratory Syndrome Coronavirus 2 Main Protease Inhibitors with Improved Antiviral Activity and Favorable Druggability 102
Caratterizzazione di nuovi composti antivirali contro il citomegalovirus umano e studio del meccanismo di neuropatogenocità nel herpesvirus equino di tipo 1 95
Human neural progenitor cell models to study the antiviral effects and neuroprotective potential of approved and investigational human cytomegalovirus inhibitors 90
Optimization of potent, broad-spectrum, and specific anti-influenza compounds targeting RNA polymerase PA-PB1 heterodimerization 84
Antiviral strategies against influenza virus: an update on approved and innovative therapeutic approaches 80
Composition and methods for the treatment of pathological condition associated with cytomegalovirus infection. 64
Novel SARS-CoV-2 allosteric inhibitors that destabilize the Main Protease Mpro dimer 26
Antiviral drug repurposing: different approaches and the case of antifungal drugs 22
Totale 7.006
Salva come PNG Salva come JPEG
Categoria #
all - tutte 21.966
article - articoli 20.801
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 236
selected - selezionate 0
volume - volumi 553
Totale 43.556
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021405 0 0 0 0 19 24 26 41 75 36 77 107
2021/2022589 10 70 90 51 47 29 34 64 13 18 59 104
2022/2023510 86 55 22 48 91 64 4 40 49 17 32 2
2023/2024388 7 51 62 26 40 33 45 27 8 32 25 32
2024/20251.388 5 156 72 47 153 52 97 102 86 70 205 343
2025/20262.116 290 395 634 787 10 0 0 0 0 0 0 0
Totale 7.006